Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1
Naringenin inhibits TNF-α induced VSMC proliferation and migration via induction of HO-1
复制标题
DOI:
10.1016/j.fct.2012.06.006
复制
发表时间:
2012-09-01
影响因子:
4.3
通讯作者:
Liu, Chang
中科院分区:
文献类型:
--
作者:
Chen, Siyu;Ding, Yan;Liu, Chang
Vascular smooth muscle cell (VSMC) proliferation and migration, which is triggered by various inflammatory stimuli, contributes importantly to the pathogenesis of atherosclerosis and restenosis. Naringenin is a citrus flavonoid with both lipid-lowering and insulin-like properties. Here, we investigated whether naringenin affects TNF-alpha-induced VSMC proliferation and migration and if so, whether heme oxygenase-1 (HO-1) is involved. Rat VSMCs were treated with naringenin alone or in combination of TNF-alpha stimulation. We found that naringenin induced HO-1 mRNA and protein levels, as well as its activity, in VSMCs. Naringenin inhibited TNF-alpha-induced VSMC proliferation and migration in a dose-dependent manner. Mechanistic study demonstrated that naringenin prevented ERK/MAPK and Akt phosphorylation while left p38 MAPK and JNK unchanged. Naringenin also blocked the increase of ROS generation induced by TNF-alpha. More importantly, the specific HO-1 inhibitor ZnPP IX or HO-1 siRNA partially abolished the beneficial effects of naringenin on VSMCs. These results suggest that naringenin may serve as a novel drug in the treatment of these pathologies by inducing HO-1 expression/activity and subsequently decreasing VSMC proliferation and migration. (C) 2012 Elsevier Ltd. All rights reserved.